The effect of Benzothiazolone-2 on the expression of Metallothionein-3 in modulating Alzheimer's disease

Abstract
Metallothioneins (MTs) are a class of ubiquitously occurring low-molecular-weight cysteine- and metal-rich proteins containing sulfur-based metal clusters. MT-3 exhibits neuro-inhibitory activity. The possibility to enhance the expression of MT-3 or protect it from degradation is an attractive therapeutic target, because low levels of MT-3 were found in brains of Alzheimer's disease (AD) patients.
Description
Citation
Brain and Behavior. 2017, vol. 7, issue 9, p. 1-9.
http://onlinelibrary.wiley.com/doi/10.1002/brb3.799/abstract
Document type
Peer-reviewed
Document version
Published version
Date of access to the full text
Language of document
en
Study field
Comittee
Date of acceptance
Defence
Result of defence
Document licence
Creative Commons Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Citace PRO